Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE: 300026)
Health Care · Pharmaceuticals · CN
CN¥3.40
-6.08% today · -20.6% 1Y
Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE: 300026) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.52B and employs 4,852 people.
Over the last twelve months the share price has lost 20.6%, trading between 2.82 and 4.32.
Tweenvest scores Tianjin Chase Sun Pharmaceutical Co.,Ltd across four factors: quality 72/100, value 38/100, growth 19/100, dividend 17/100. Its strongest factor is quality.
300026 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.52B
- Revenue (TTM)
- $678.31M
- P/E
- 272.92
- EPS
- 0.01
- Dividend yield
- 0.29%
- Beta (5Y)
- 0.03
- 52-week high
- CN¥4.32
- 52-week low
- CN¥2.82
- Avg volume (3M)
- —
- Shares outstanding
- 3.00B
- Employees
- 4,852
- Next earnings
- —
About Tianjin Chase Sun Pharmaceutical Co.,Ltd
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases. The company was founded in 1996 and is headquartered in Tianjin, China.
- ISIN
- CNE100000GF1
- Founded
- 1996
- Listed since
- Oct 30, 2009
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.